SPX and obesity due to melanocortin 4 receptor deficiency: Recent clinical investigations indicate spexin is an important peptide involved in obesity and diabetes (Kumar et al., 2016, 2017; Hodges et al., 2017; Kolodziejskii et al., 2017), consistently supported by the current finding that long-term injection of spexin decreased the gain in body weight, in mice.